Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
about
BRCA1 is an essential regulator of heart function and survival following myocardial infarctionHeart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference?The Role of Biomarkers in Decreasing Risk of Cardiac Toxicity after Cancer TherapyPathophysiology and preventive strategies of anthracycline-induced cardiotoxicityThe Crossroads of Geriatric Cardiology and Cardio-OncologyMultimodality Imaging in CardiooncologyUnderstanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonanceCardiac effects of anticancer therapy in the elderlyCardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next LevelEvaluation and management of patients with heart disease and cancer: cardio-oncologyThe effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancerHypertension in patients with cancerThe emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitorsIncidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomibNoninvasive imaging of cardiovascular injury related to the treatment of cancerUse of biomarkers for the assessment of chemotherapy-induced cardiac toxicity.Suivi après le traitement du cancer du sein: Guide pratique des soins aux survivantes à l’intention des médecins de familleFollow-up after treatment for breast cancer: Practical guide to survivorship care for family physiciansCurrent Views on Anthracycline Cardiotoxicity in Childhood Cancer SurvivorsRecent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic DrugsAngiogenesis inhibitor bevacizumab increases the risk of ischemic heart disease associated with chemotherapy: a meta-analysisROCK1 deficiency enhances protective effects of antioxidants against apoptosis and cell detachmentEffects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytesDissecting the Mechanisms of Doxorubicin and Oxidative Stress-Induced Cytotoxicity: The Involvement of Actin Cytoskeleton and ROCK1Supervised Machine Learning for Classification of the Electrophysiological Effects of Chronotropic Drugs on Human Induced Pluripotent Stem Cell-Derived CardiomyocytesManagement of CAD in Patients with Active Cancer: the Interventional Cardiologists' PerspectiveCancer drug related cardiotoxicity during breast cancer treatment.Chemotherapy-Induced Cardiotoxicity: Pathophysiology and PreventionExpert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.Subclinical ventricular dysfunction detected by speckle tracking two years after use of anthracycline.Cardiac complications of chemotherapy: role of imaging.Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.Management of chemotherapy induced cardiomyopathy.High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells.Primary cardiac lymphoma with isolated parenchymal central nervous system relapse: report of two cases and review of the literature.Heart failure following cancer treatment: characteristics, survival and mortality of a linked health data analysis.Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors.A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma.Ischemic Heart Disease: Special Considerations in Cardio-Oncology.Proteasome inhibitors and cardiac cell growth
P2860
Q24300290-884E8465-49D4-4C1D-9E93-39B3FF1DA36EQ26740352-6B7EB11C-1416-4502-BF0F-74E310591372Q26743433-7111E94C-EDA8-4032-9C6E-A76D1CBF8553Q26744675-7885006E-961C-46A1-BADC-EAF9BDBBD523Q26778666-D537C80B-FE80-4B7C-857A-AF1EA2F6C113Q26795452-68677624-B930-43B1-8DF1-278B1AEEB28FQ26859193-6DAC910A-84E1-488A-94BF-D4167230DDC2Q26863244-401FA85A-CA6D-42EE-A381-40EC4AA76421Q26864094-7243F578-AC5D-43B1-8778-80D46FB0A57DQ26998273-6720D55B-D94C-4C07-86DD-7B16FF0A4AACQ26999300-09B2C3A3-F8F5-4943-9698-B913F1CBE5BCQ27003980-9F1EA19F-E7AB-46CD-97B4-94115B8213C4Q27011540-E06459B3-A561-4C3E-B5D8-67758CBFF095Q27014143-D9235E73-BB73-4CA2-B5C0-E37DDC98105CQ27024715-CDC05877-3B63-4185-8494-F5B7B1BB9B20Q27027354-C557983B-6272-48AD-A131-D36B01ED777AQ28078524-DC3CFD0C-5AEC-47AD-91D1-A092F9C3BC15Q28080263-43F84CDF-0C43-4AF3-86DB-CD558603A3BCQ28083073-B479024F-8B9D-45BD-BE2B-6BD40998BE7EQ28087776-92E6CAA3-F968-4B9C-B174-4BF25C811E66Q28534015-D95167FE-312C-4EB8-A080-777BC9A526B2Q28540406-659DED80-0BFB-4615-A049-C5F573A48118Q28543397-8B635351-44E0-4E27-83FD-49890C045E1AQ28546141-E7A21B60-4A89-4993-84EF-BE7A4DDAB2E2Q28551775-11AF2C85-0B38-4878-BC3C-435F185713EBQ29994512-D0B219F0-D55F-4F4E-9CBF-13F748770F07Q30251498-73B75814-35AF-4A8C-BA2F-33FEB840C9D7Q30399577-D7BA3610-4E66-4100-AF48-15EE01D063AFQ30401812-B1C13B4D-9FED-4496-BE74-29CD6A8A2463Q30412756-ADF18307-F016-4126-B09D-08362EABD28CQ30415201-6A2956F5-7BCC-42EC-96BA-BBC8F0E7F007Q30446509-BF52FCEC-4F72-4A9B-93ED-25664515F916Q30461441-B045265E-733F-4F51-A9EF-64BB579E3E4BQ30847302-0012333D-C1A7-4824-A2A8-D27D992E975FQ30867952-817FE8E9-791E-46B1-89D7-5D9FA0CA029BQ31120288-3069601C-2154-4801-9276-9786E01D6F1AQ33352155-90F728B8-2346-484F-AE47-26A0D3D12EA0Q33416105-0FFAB870-38F3-4AD8-A28E-2E0C6E40ADCBQ33441165-83B67789-1E95-461F-B7B6-58D8FD36EBCFQ33554490-678A8416-01B4-4488-82A5-0E5DD8EB4743
P2860
Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular complications o ...... is, diagnosis, and management.
@en
Cardiovascular complications o ...... is, diagnosis, and management.
@nl
type
label
Cardiovascular complications o ...... is, diagnosis, and management.
@en
Cardiovascular complications o ...... is, diagnosis, and management.
@nl
prefLabel
Cardiovascular complications o ...... is, diagnosis, and management.
@en
Cardiovascular complications o ...... is, diagnosis, and management.
@nl
P921
P1476
Cardiovascular complications o ...... is, diagnosis, and management.
@en
P2093
Courtney L Bickford
Edward T H Yeh
P304
P356
10.1016/J.JACC.2009.02.050
P407
P577
2009-06-01T00:00:00Z